{
  "documentMetadata": {
    "title": "Endocarditis, Bartonella sp.",
    "lastUpdated": "2024-04-24",
    "sourceFile": "Endocarditis, Bartonella sp..pdf"
  },
  "content": [
    {
      "type": "header",
      "level": 1,
      "text": "Clinical Setting"
    },
    {
      "type": "list",
      "items": [
        "Bartonella is the second most common cause of culture-negative endocarditis",
        "Bartonella quintana endocarditis is associated with alcoholism, homelessness and body lice.",
        "Bartonella henselae is associated with cats and valvular disease."
      ]
    },
    {
      "type": "header",
      "level": 1,
      "text": "Diagnosis"
    },
    {
      "type": "list",
      "items": [
        "Methods (see J Clin Micro 2021.59: e02217-20 for advantages and limitations of these methods):",
        "Positive serology",
        "Recommend EIA",
        "Titer of â‰¥ 1:800 good correlation with infective endocarditis",
        "NOTE: low titer cross-reactivity with Coxiella burnetii, Brucella spp, and rarely Enterococcus faecalis",
        "Bartonella-specific RT-PCR of resected heart valve",
        "Valve tissue histopathology",
        "Culture for Bartonella sp. (Rarely positive)"
      ]
    },
    {
      "type": "header",
      "level": 1,
      "text": "Primary Regimens"
    },
    {
      "type": "list",
      "items": [
        "Due to risk of relapse, treatment of bartonella endocarditis is prolonged. Suggest repeat antibody titers every 6-8 weeks as guide to duration of therapy.",
        "Specific therapy:"
      ]
    },
    {
      "type": "drugRegimen",
      "regimenData": {
        "intent": "treatment",
        "components": [
          {
            "drug": "Doxycycline",
            "dose": "100 mg",
            "route": "IV/po",
            "frequency": "bid",
            "connector": "+"
          },
          {
            "drug": "Gentamicin",
            "dose": "1 mg/kg",
            "route": "IV",
            "frequency": "q8h"
          }
        ],
        "durationDetail": {
          "fixedDuration": "6 weeks and first 2 weeks"
        },
        "notes": "Gentamicin target serum levels: peak 3-4 ug/mL and trough <1 ug/mL. Duration of Doxycycline therapy depends on valve resection surgery: If infected valve is resected, continue Doxycycline for another 6 wks. If no valve surgery, continue Doxycycline for another 3 months"
      }
    },
    {
      "type": "drugRegimen",
      "regimenData": {
        "intent": "treatment",
        "condition": "If cannot use Doxycycline, substitute",
        "components": [
          {
            "drug": "Azithromycin",
            "dose": "500 mg",
            "route": "IV/po",
            "frequency": "once daily",
            "connector": "+"
          },
          {
            "drug": "Gentamicin"
          }
        ],
        "durationDetail": {
          "fixedDuration": "14 days"
        },
        "notes": "If infected valve is surgically resected, continue Azithromycin for another 3 months. If infected valve is not resected, continue Azithromycin for another 6 months"
      }
    },
    {
      "type": "header",
      "level": 1,
      "text": "Alternative Regimens"
    },
    {
      "type": "drugRegimen",
      "regimenData": {
        "intent": "treatment",
        "condition": "If Gentamicin toxicity precludes its use, consultation is suggested",
        "components": [
          {
            "drug": "Doxycycline",
            "notes": "as above",
            "connector": "+"
          },
          {
            "drug": "Rifampin",
            "dose": "300 mg",
            "route": "IV/po",
            "frequency": "bid"
          }
        ],
        "durationDetail": {
          "fixedDuration": "first 14 days"
        }
      }
    },
    {
      "type": "header",
      "level": 1,
      "text": "Antimicrobial Stewardship"
    },
    {
      "type": "list",
      "items": [
        "Resistance of Bartonella to Doxycyline has not been documented; hence treatment failures likely indicate relapse, not resistance.",
        "TMP-SMX, fluoroquinolones, 1st generation cephalosporins and penicillins are not predictably active against Bartonella quintana and should not be used."
      ]
    },
    {
      "type": "header",
      "level": 1,
      "text": "Comment"
    },
    {
      "type": "list",
      "items": [
        "Review: Copycat. N Engl J Med. 2021;385: 1797"
      ]
    }
  ]
}